Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Vaway vs VFEND (Voriconazole) in Healthy Adults
NCT02912156Phase 4Completed
- Sponsor
- Yung Shin Pharmaceutical Industry
- Start
- Jun 2016
- Primary completion
- Jul 2016
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised trial of voriconazole in fungal infection, sponsored by Yung Shin Pharmaceutical Industry. Primary endpoint: Area under the plasma concentration at 36 hours. Started Jun 2016; status: completed.
02
Drugs
voriconazole
03
Conditions
fungal infection
Beyond the preview
Go deeper on NCT02912156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02912156.